Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifabutin with lopinavir/ritonavir in HIV and tuberculosis coinfection
PACTR201310000629390Recruiting
- Sponsor
- IRESSEF
- Start
- Nov 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of rifabutin, lopinavir and ritonavir in human immunodeficiency virus infection (HIV) and pulmonary tuberculosis (TB), sponsored by IRESSEF. Primary endpoints: Area under the curve of rifabutin and Area under the curve of lopinavir/ritonavir. Started Nov 2013; status: recruiting.
02
Drugs
rifabutinlopinavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on PACTR201310000629390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201310000629390.